Delivery Order SPE2DB22D1202-SPE2DB24FUZC5

Award Date 5/2/24
Potential Completion Date 5/3/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,421.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,116,082 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of May 5, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $1,152.43, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,260,982 units of Dextroamphetamine ER 10 mg capsules in 100 count bottles. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025, to supply pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $2,497.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,466,189 units of the drug dextroamphetamine-amphetamine ER 10 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a range of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,830.47 firm-fixed-price delivery order is for the supply of 4,565,712,396 units of dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of September 9, 2024. This award is a task order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for $2,097.52. The order is for Dextroamphetamine-Amphetamine 25 mg capsules, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $1,038.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.64 firm fixed-price delivery order is for the supply of 4,566,790,127 dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.54 firm fixed-price delivery order is for the supply of 4,568,234,911 units of the medication Dextroamphetamine-Amphetamine 20 mg capsules. The contract has a period of performance through May 14, 2025 and is not set aside for any small business designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,724,223 dextroamphetamine 20 mg tablets in packages of 30. The fixed-price delivery order, valued at $1,080.66, has a completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, valued at $3,492.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUZC5
    Delivery Order

This federal contract award, valued at $1,686.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a delivery order for the supply of 4,564,479,343 units of Dextroamphetamine-Amphetamine 20 mg capsules in 100s. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies in support of the Department of Defense's healthcare programs. This specific delivery order does not have a set-aside designation.

Generated 8/1/24, 10:12 AM